The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | SHS | G01767105 | 252,713,202 | 8,964,640 | SH | SOLE | 8,964,640 | 0 | 0 | |||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 7,365,000 | 4,910,000 | SH | SOLE | 4,910,000 | 0 | 0 | |||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 6,463,500 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | |||
| BIOGEN INC | COM | 09062X103 | 178,773,290 | 643,000 | SH | SOLE | 643,000 | 0 | 0 | |||
| GILEAD SCIENCES INC | COM | 375558103 | 70,524,500 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | |||
| INNOVIVA INC | COM | 45781M101 | 74,407,500 | 6,614,000 | SH | SOLE | 6,614,000 | 0 | 0 | |||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 172,422,800 | 16,390,000 | SH | SOLE | 16,390,000 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 15,618,000 | 3,800,000 | SH | SOLE | 3,800,000 | 0 | 0 | |||
| PEAR THERAPEUTICS INC | CLASS A COM | 704723105 | 127,591 | 500,356 | SH | SOLE | 500,356 | 0 | 0 | |||
| REGULUS THERAPEUTICS INC | COM | 75915K309 | 156,943 | 185,183 | SH | SOLE | 185,183 | 0 | 0 | |||
| VOR BIOPHARMA INC | COM | 929033108 | 3,324,840 | 618,000 | SH | SOLE | 618,000 | 0 | 0 | |||